Brimonidine in the treatment of glaucoma and ocular hypertension
about
sameAs
Clinical effectiveness of brinzolamide 1%-brimonidine 0.2% fixed combination for primary open-angle glaucoma and ocular hypertensionManagement of glaucoma in pregnancy: risks or choices, a dilemma?Use of topical brimonidine to prevent intraocular pressure elevations following Nd: YAG-laser posterior capsulotomy.The efficacy and safety of add-on 0.1% brimonidine tartrate preserved with sodium chlorite in on-treatment Japanese normal-tension glaucoma patientsNatural Bioadhesive Biodegradable Nanoparticle-Based Topical Ophthalmic Formulations for Management of Glaucoma.Cumulative mtDNA damage and mutations contribute to the progressive loss of RGCs in a rat model of glaucomaFixed combinations of dorzolamide-timolol and brimonidine-timolol in the management of glaucoma.Brinzolamide/brimonidine: a review of its use in patients with open-angle glaucoma or ocular hypertension.Biochemical changes and treatment in glaucoma.Clinical outcomes of combined versus separate carbachol and brimonidine drops in correcting presbyopia.Brimonidine and brinzolamide for treating glaucoma and ocular hypertension; a safety evaluation.A validated stability-indicating HPLC method for determination of brimonidine tartrate in BRI/PHEMA drug delivery systems.Formulation and ex vivo-in vivo evaluation of pH-triggered brimonidine tartrate in situ gel for the glaucoma treatment using application of 32 factorial design.Validated spectrofluorimetric and spectrophotometric methods for the determination of brimonidine tartrate in ophthalmic solutions via derivatization with NBD-Cl. Application to stability study.Efficacy of three different formulations of brimonidine for control of intraocular pressure in primary open-angle glaucoma: A 6-week randomized trial.
P2860
Q26773219-B9807AD0-C5D0-43BE-A4B6-073591011EF1Q28068244-345124CC-B242-42D2-91F2-5C0A2AACDEFDQ33965972-8FE63280-35B4-4C54-BCBE-C4C56052D4F6Q34156443-10148A27-D84E-4EAB-AAF5-01D562F79753Q35691647-AECA0DF5-08F4-48AC-AF57-A212C016DC59Q35911424-13746D41-8D6E-4596-A891-3D0F6E41DA66Q37716010-A4D4FE12-FEFD-420B-8F78-C4A7161F24FEQ38366857-F1E7A34D-0211-4FC2-A0A6-852503E6C628Q38443580-7F2720C7-B73D-4CFF-94B0-DF8D55A1560FQ39096490-CADF7FFB-7197-43FD-BFAD-14F8850756BBQ39401937-E7DBB882-AE51-4D3C-9AA2-E80B740BCB4CQ42943888-785C0F53-A7E3-4A21-91E6-238ACBD92C7DQ47329132-C3C7197D-AC26-4D6F-9F41-982B24F308A8Q51065900-47F896C3-B0F1-454F-8B8C-013A249F5C86Q55322496-7245508F-35E6-4E77-8C02-16C4FE5F19C9
P2860
Brimonidine in the treatment of glaucoma and ocular hypertension
description
2006 nî lūn-bûn
@nan
2006 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
name
Brimonidine in the treatment of glaucoma and ocular hypertension
@ast
Brimonidine in the treatment of glaucoma and ocular hypertension
@en
Brimonidine in the treatment of glaucoma and ocular hypertension
@en-gb
Brimonidine in the treatment of glaucoma and ocular hypertension
@nl
type
label
Brimonidine in the treatment of glaucoma and ocular hypertension
@ast
Brimonidine in the treatment of glaucoma and ocular hypertension
@en
Brimonidine in the treatment of glaucoma and ocular hypertension
@en-gb
Brimonidine in the treatment of glaucoma and ocular hypertension
@nl
prefLabel
Brimonidine in the treatment of glaucoma and ocular hypertension
@ast
Brimonidine in the treatment of glaucoma and ocular hypertension
@en
Brimonidine in the treatment of glaucoma and ocular hypertension
@en-gb
Brimonidine in the treatment of glaucoma and ocular hypertension
@nl
P2860
P1476
Brimonidine in the treatment of glaucoma and ocular hypertension
@en
P2093
Louis B Cantor
P2860
P304
P356
10.2147/TCRM.2006.2.4.337
P407
P577
2006-12-01T00:00:00Z